NCT06391788View on ClinicalTrials.gov

Efficacy and Safety of Thoracoscopic Morrow Surgery in the Treatment of Hypertrophic Obstructive Cardiomyopathy

NARecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

February 1, 2025

Study Completion Date

March 31, 2025

Conditions
Cardiomyopathy, Hypertrophic ObstructiveMinimally Invasive Surgery
Interventions
PROCEDURE

thoracoscopic Morrow surgery

minimally invasive trans-mitral Morrow septal myectomy

PROCEDURE

modified Morrow surgery

median open modified enlarged Morrow septal myectomy

Trial Locations (1)

Unknown

RECRUITING

Fuwai Hospital, National Centre for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors
lead

China National Center for Cardiovascular Diseases

OTHER_GOV